Koninklijke DSM N.V. (DSM.AS)
Chart Events
Performance Outlook
| Previous Close | 136.65 |
| Open | 137.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 136.05 - 139.70 |
| 52 Week Range | 133.90 - 200.50 |
| Volume | |
| Avg. Volume | 432,298 |
| Market Cap | 23.532B |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | 14.12 |
| EPS (TTM) | 9.64 |
| Earnings Date | Aug 02, 2022 |
| Forward Dividend & Yield | 2.50 (1.84%) |
| Ex-Dividend Date | May 12, 2022 |
| 1y Target Est | 185.13 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for DSM.AS
Related Research
- PR Newswire
DSM announces final dividend for 2021
Royal DSM, a global purpose-led science-based company, confirmed its resolution to declare a dividend for the financial year 2021 of €2.50 per ordinary share was passed today, 10 May 2022, at its Annual General Meeting of Shareholders. This represents an increased dividend versus the €2.40 paid for 2020. An interim dividend of €0.80 per ordinary share having been paid in August 2021, the final dividend thus amounts to €1.70 per ordinary share.
- PR Newswire
DSM announces results of 2022 Annual General Meeting of Shareholders
Royal DSM, a global purpose-led science-based company, today held its Annual General Meeting of Shareholders.
- PR Newswire
DSM - repurchase of shares (2-6 May 2022)
Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of €156.08. This is in accordance with the repurchase program announced on 10 March 2022, covering the commitments for the final stock dividend 2021 and share based compensation plans. The consideration of this repurchase was €6.3 million.
